• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • In the news: Global health

    Access to generic medicine to continue with ‘death’ of ACTA

    The European Parliament has rejected the contentious Anti-Counterfeiting Trade Agreement in a move lauded by nongovernmental organizations championing global access to generic medicines.

    By Ivy Mungcal // 04 July 2012
    The European Parliament has rejected the Anti-Counterfeiting Trade Agreement. Four hundred seventy-eight members of the Parliament voted against ACTA. Photo by: © European Union 2012 - European Parliament / CC BY-NC-ND

    The European Parliament has rejected the contentious Anti-Counterfeiting Trade Agreement in a move lauded by nongovernmental organizations championing global access to generic medicines.

    A majority of European Parliament members – 478 out of 682 – voted July 4 (Wednesday) against ratifying ACTA. With this vote, no EU member state is allowed to join the agreement.

    Oxfam International said the vote effectively scraps ACTA, which aims to establish a legal framework against counterfeit goods, despite the agreement having the support of countries such as Australia, Canada, South Korea and the United States.

    Europe’s decision is a “victory for poor people over the interest of big pharmaceutical companies,” Oxfam said. Some provisions of ACTA would have made life-saving medicines too expensive for the world’s poor, the group explained.

    Médecins Sans Frontières, another proponent of access to affordable generic medicines, also welcomed the European Parliament’s vote. It urged the European Commission to now review other “harmful intellectual property provisions” included in other trade agreements.

    Read more:

    • ACTA: More than just a piracy issue

    Read more development aid news online, and subscribe to The Development Newswire to receive top international development headlines from the world’s leading donors, news sources and opinion leaders — emailed to you FREE every business day.

    • Democracy, Human Rights & Governance
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Ivy Mungcal

      Ivy Mungcal

      As former senior staff writer, Ivy Mungcal contributed to several Devex publications. Her focus is on breaking news, and in particular on global aid reform and trends in the United States, Europe, the Caribbean, and the Americas. Before joining Devex in 2009, Ivy produced specialized content for U.S. and U.K.-based business websites.

    Search for articles

    Most Read

    • 1
      Lasting nutrition and food security needs new funding — and new systems
    • 2
      The power of diagnostics to improve mental health
    • 3
      The UN's changing of the guard
    • 4
      The top local employers in Europe
    • 5
      Opinion: Urgent action is needed to close the mobile gender gap
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement